Phlox Therapeutics

Seed
phloxtherapeutics.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Seed
Last Announced Dec 11, 2024
Investors Undisclosed
Decision Makers Profile Active

About Phlox Therapeutics

We pioneer in gene therapy to cure genetic heart diseases. Our goal is to cure cardiac dysfunction by developing new precision medicines.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Undisclosed
Tracked Since Nov 8, 2026

Web & Domain Identity

Official Website phloxtherapeutics.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

3 Events
  1. Capital Raise

    Raised undisclosed · Seed

    fundraisingfox.com

  2. Capital Raise

    Raised undisclosed · Seed

    fundraisingfox.com

  3. Capital Raise

    Raised undisclosed · Seed

    fundraisingfox.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Phlox Therapeutics.

Funding History

3 Rounds
Seed equity · Dec 11, 2024
Seed equity · May 9, 2023
Seed equity · May 16, 2022

Founders & Leadership

2

dr. Eva Van Rooij

Founder and CSO

Work email & phone locked Unlock →

dr. Yigal Pinto

Founder and CMO

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts